Speaker illustration

Doctor Frederik Dalgaard

Gentofte University Hospital, Gentofte (Denmark)

Frederik Dalgaard, MD graduated from the University of Copenhagen in 2015. Since then, he has pursued an active career in cardiovascular research. He is currently doing a PhD in cardiovascular medicine at Herlev and Gentofte Hospital, Copenhagen, Denmark and he has recently graduated as a research fellow in cardiovascular medicine at Duke Clinical Research Institute. His area of research involves atrial fibrillation, pacing, pharmacoepidemiology, multimorbidity, and primary prevention of cardiovascular disease.

Cardiac resynchronization therapy in patients with a history of atrial fibrillation: insights from five major clinical trials

Event: EHRA 2022

Topic: Device Treatment

Session: CRT news

Thumbnail

Rate versus rhythm control and mortality in atrial fibrillation patients: a danish nationwide cohort study

Event: ESC CONGRESS 2019

Topic: Treatment

Session: Blockbusters from the Young in atrial fibrillation and cardiac resynchronisation therapy

Thumbnail

Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology of atrial fibrillation, miscellaneous

Thumbnail

Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation

Event: EHRA 2018

Topic: Antiarrhythmic Drug Treatment

Session: Young EP Poster Session - Young meets Experienced

Thumbnail

Risk factors of permanent pacemaker implantation in patients with new onset atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Risk scores

Session: Adverse outcome in patients with cardiometabolic disorders

Thumbnail

ESC 365 is supported by

logo Novo Nordisk